Published in Nat Neurosci on June 18, 2006
Neural mechanisms of extinction learning and retrieval. Neuropsychopharmacology (2007) 7.57
Plastic synaptic networks of the amygdala for the acquisition, expression, and extinction of conditioned fear. Physiol Rev (2010) 4.59
Dissociable roles of prelimbic and infralimbic cortices, ventral hippocampus, and basolateral amygdala in the expression and extinction of conditioned fear. Neuropsychopharmacology (2010) 3.96
A genetic variant BDNF polymorphism alters extinction learning in both mouse and human. Science (2010) 3.61
Histone modifications around individual BDNF gene promoters in prefrontal cortex are associated with extinction of conditioned fear. Learn Mem (2007) 2.99
BDNF: a key regulator for protein synthesis-dependent LTP and long-term memory? Neurobiol Learn Mem (2007) 2.96
Hippocampus-specific deletion of BDNF in adult mice impairs spatial memory and extinction of aversive memories. Mol Psychiatry (2007) 2.84
Induction of fear extinction with hippocampal-infralimbic BDNF. Science (2010) 2.27
Effect of 7,8-dihydroxyflavone, a small-molecule TrkB agonist, on emotional learning. Am J Psychiatry (2010) 2.25
How the neurocircuitry and genetics of fear inhibition may inform our understanding of PTSD. Am J Psychiatry (2010) 2.24
Changing fear: the neurocircuitry of emotion regulation. Neuropsychopharmacology (2010) 2.18
Fear conditioning, synaptic plasticity and the amygdala: implications for posttraumatic stress disorder. Trends Neurosci (2011) 2.12
Neural and cellular mechanisms of fear and extinction memory formation. Neurosci Biobehav Rev (2012) 1.94
Seeking a spotless mind: extinction, deconsolidation, and erasure of fear memory. Neuron (2011) 1.80
mGluR5 has a critical role in inhibitory learning. J Neurosci (2009) 1.76
Prelimbic cortical BDNF is required for memory of learned fear but not extinction or innate fear. Proc Natl Acad Sci U S A (2010) 1.72
Fear extinction causes target-specific remodeling of perisomatic inhibitory synapses. Neuron (2013) 1.72
Implications of memory modulation for post-traumatic stress and fear disorders. Nat Neurosci (2013) 1.72
A simple role for BDNF in learning and memory? Front Mol Neurosci (2010) 1.68
Amygdala volume in major depressive disorder: a meta-analysis of magnetic resonance imaging studies. Mol Psychiatry (2008) 1.67
Glutamate receptors in extinction and extinction-based therapies for psychiatric illness. Neuropsychopharmacology (2010) 1.51
Variant BDNF Val66Met polymorphism affects extinction of conditioned aversive memory. J Neurosci (2009) 1.46
Dissociable roles for the ventromedial prefrontal cortex and amygdala in fear extinction: NR2B contribution. Cereb Cortex (2008) 1.45
Sex differences, gonadal hormones and the fear extinction network: implications for anxiety disorders. Biol Mood Anxiety Disord (2012) 1.44
Beta-catenin is required for memory consolidation. Nat Neurosci (2008) 1.40
A hippocampal Cdk5 pathway regulates extinction of contextual fear. Nat Neurosci (2007) 1.35
PTSD and gene variants: new pathways and new thinking. Neuropharmacology (2011) 1.34
Fear extinction and BDNF: translating animal models of PTSD to the clinic. Genes Brain Behav (2012) 1.31
A naturally-occurring histone acetyltransferase inhibitor derived from Garcinia indica impairs newly acquired and reactivated fear memories. PLoS One (2013) 1.30
Hippocampal Mek/Erk signaling mediates extinction of contextual freezing behavior. Neurobiol Learn Mem (2006) 1.29
Extinction of drug- and withdrawal-paired cues in animal models: relevance to the treatment of addiction. Neurosci Biobehav Rev (2010) 1.19
Understanding resilience. Front Behav Neurosci (2013) 1.19
Hippocampal--prefrontal BDNF and memory for fear extinction. Neuropsychopharmacology (2014) 1.14
Epigenetic modulation of Homer1a transcription regulation in amygdala and hippocampus with pavlovian fear conditioning. J Neurosci (2012) 1.12
A behavioral analysis of the impact of voluntary physical activity on hippocampus-dependent contextual conditioning. Hippocampus (2009) 1.12
Endocannabinoid influence in drug reinforcement, dependence and addiction-related behaviors. Pharmacol Ther (2011) 1.08
Proteolysis of proBDNF is a key regulator in the formation of memory. PLoS One (2008) 1.07
Ethanol-BDNF interactions: still more questions than answers. Pharmacol Ther (2008) 1.06
Genetic variation in brain-derived neurotrophic factor and human fear conditioning. Genes Brain Behav (2009) 1.05
Differential regional expression of brain-derived neurotrophic factor following olfactory fear learning. Learn Mem (2007) 1.01
Prelimbic BDNF and TrkB signaling regulates consolidation of both appetitive and aversive emotional learning. Transl Psychiatry (2012) 1.00
Pharmacological enhancement of fear reduction: preclinical models. Br J Pharmacol (2011) 0.99
Deoxygedunin, a natural product with potent neurotrophic activity in mice. PLoS One (2010) 0.99
Deep brain stimulation, histone deacetylase inhibitors and glutamatergic drugs rescue resistance to fear extinction in a genetic mouse model. Neuropharmacology (2012) 0.98
Identification of cell-type-specific promoters within the brain using lentiviral vectors. Gene Ther (2007) 0.98
Stress and Fear Extinction. Neuropsychopharmacology (2015) 0.98
Role of activity-dependent BDNF expression in hippocampal-prefrontal cortical regulation of behavioral perseverance. Proc Natl Acad Sci U S A (2013) 0.98
Deep brain stimulation of the ventral striatum increases BDNF in the fear extinction circuit. Front Behav Neurosci (2013) 0.98
Amygdala-dependent fear conditioning in humans is modulated by the BDNFval66met polymorphism. Behav Neurosci (2010) 0.96
Endocannabinoid-mediated synaptic plasticity and addiction-related behavior. Neuropharmacology (2011) 0.94
From the neurobiology of extinction to improved clinical treatments. Depress Anxiety (2013) 0.94
Learning and memory deficits in mice lacking protease activated receptor-1. Neurobiol Learn Mem (2007) 0.93
The Use of Lentiviral Vectors and Cre/loxP to Investigate the Function of Genes in Complex Behaviors. Front Mol Neurosci (2009) 0.93
Effect of BDNF val66met polymorphism on age-related amygdala volume changes in healthy subjects. Prog Neuropsychopharmacol Biol Psychiatry (2008) 0.93
Pharmacology of cognitive enhancers for exposure-based therapy of fear, anxiety and trauma-related disorders. Pharmacol Ther (2014) 0.92
Region-specific involvement of BDNF secretion and synthesis in conditioned taste aversion memory formation. J Neurosci (2011) 0.91
3,4-Methylenedioxymethamphetamine facilitates fear extinction learning. Transl Psychiatry (2015) 0.91
Genetic approaches to understanding post-traumatic stress disorder. Int J Neuropsychopharmacol (2013) 0.90
Learning not to fear: neural correlates of learned safety. Neuropsychopharmacology (2013) 0.90
Angiotensin type 1 receptor inhibition enhances the extinction of fear memory. Biol Psychiatry (2013) 0.89
Synaptic regulation of affective behaviors; role of BDNF. Neuropharmacology (2013) 0.89
Epigenetic mechanisms underlying extinction of memory and drug-seeking behavior. Mamm Genome (2009) 0.89
Stress modulation of cognitive and affective processes. Stress (2011) 0.87
Mechanisms to medicines: elucidating neural and molecular substrates of fear extinction to identify novel treatments for anxiety disorders. Br J Pharmacol (2014) 0.86
BDNF deletion or TrkB impairment in amygdala inhibits both appetitive and aversive learning. J Neurosci (2014) 0.85
Effect of D-cycloserine and valproic acid on the extinction of reinstated fear-conditioned responses and habituation of fear conditioning in healthy humans: a randomized controlled trial. Psychopharmacology (Berl) (2011) 0.85
HDAC activity is required for BDNF to increase quantal neurotransmitter release and dendritic spine density in CA1 pyramidal neurons. Hippocampus (2011) 0.83
Exercise Augmentation of Exposure Therapy for PTSD: Rationale and Pilot Efficacy Data. Cogn Behav Ther (2015) 0.82
Continuous decrease in serum brain-derived neurotrophic factor (BDNF) levels in a neuropsychiatric syndrome of systemic lupus erythematosus patient with organic brain changes. Neuropsychiatr Dis Treat (2008) 0.81
Mice lacking TrkB in parvalbumin-positive cells exhibit sexually dimorphic behavioral phenotypes. Behav Brain Res (2014) 0.81
Enhanced extinction of cocaine seeking in brain-derived neurotrophic factor Val66Met knock-in mice. Eur J Neurosci (2012) 0.80
A new theoretical approach to the functional meaning of sleep and dreaming in humans based on the maintenance of 'predictive psychic homeostasis'. Commun Integr Biol (2011) 0.79
Co-localization of caldesmon and calponin with cortical afferents, metabotropic glutamate and neurotrophic receptors in the lateral and central nuclei of the amygdala. Brain Res (2008) 0.78
Neural regulation of the time course for cocaine-cue extinction consolidation in rats. Eur J Neurosci (2012) 0.78
Escitalopram alters gene expression and HPA axis reactivity in rats following chronic overexpression of corticotropin-releasing factor from the central amygdala. Psychoneuroendocrinology (2012) 0.77
Activity-dependent signaling: influence on plasticity in circuits controlling fear-related behavior. Curr Opin Neurobiol (2015) 0.76
Formation of aversive memories associated with conditioned drug withdrawal requires BDNF expression in the amygdala in acute morphine-dependent rats. Acta Pharmacol Sin (2015) 0.76
The Combination of Long-term Ketamine and Extinction Training Contributes to Fear Erasure by Bdnf Methylation. Front Cell Neurosci (2017) 0.75
The Role of BDNF in the Development of Fear Learning. Depress Anxiety (2016) 0.75
Proteolytic cleavage of proBDNF into mature BDNF in the basolateral amygdala is necessary for defeat-induced social avoidance. Learn Mem (2016) 0.75
Neuroimaging genetic approaches to Posttraumatic Stress Disorder. Exp Neurol (2016) 0.75
TrkB blockade in the hippocampus after training or retrieval impairs memory: protection from consolidation impairment by histone deacetylase inhibition. J Neural Transm (Vienna) (2015) 0.75
Basolateral amygdala and stress-induced hyperexcitability affect motivated behaviors and addiction. Transl Psychiatry (2017) 0.75
Pre-synaptic TrkB in basolateral amygdala neurons mediates BDNF signaling transmission in memory extinction. Cell Death Dis (2017) 0.75
Neurons in medial prefrontal cortex signal memory for fear extinction. Nature (2002) 8.43
The endogenous cannabinoid system controls extinction of aversive memories. Nature (2002) 7.19
Cognitive enhancers as adjuncts to psychotherapy: use of D-cycloserine in phobic individuals to facilitate extinction of fear. Arch Gen Psychiatry (2004) 5.26
The role of ventromedial prefrontal cortex in the recovery of extinguished fear. J Neurosci (2000) 4.79
Facilitation of conditioned fear extinction by systemic administration or intra-amygdala infusions of D-cycloserine as assessed with fear-potentiated startle in rats. J Neurosci (2002) 4.52
BDNF function in adult synaptic plasticity: the synaptic consolidation hypothesis. Prog Neurobiol (2005) 4.34
Extinction of fear-potentiated startle: blockade by infusion of an NMDA antagonist into the amygdala. J Neurosci (1992) 3.40
Neurotrophins and time: different roles for TrkB signaling in hippocampal long-term potentiation. Neuron (1997) 3.03
Brain-derived neurotrophic factor and tyrosine kinase receptor B involvement in amygdala-dependent fear conditioning. J Neurosci (2004) 2.73
trkB, a neural receptor protein-tyrosine kinase: evidence for a full-length and two truncated receptors. Mol Cell Biol (1991) 2.48
Regulation of synaptic plasticity genes during consolidation of fear conditioning. J Neurosci (2002) 2.10
Consolidation of extinction learning involves transfer from NMDA-independent to NMDA-dependent memory. J Neurosci (2001) 2.05
L-type voltage-gated calcium channels are required for extinction, but not for acquisition or expression, of conditional fear in mice. J Neurosci (2002) 1.61
Neural circuitry of anxiety: evidence from structural and functional neuroimaging studies. Psychopharmacol Bull (2003) 1.48
Facilitation of memory for extinction of drug-induced conditioned reward: role of amygdala and acetylcholine. Learn Mem (2004) 1.13
Association of FKBP5 polymorphisms and childhood abuse with risk of posttraumatic stress disorder symptoms in adults. JAMA (2008) 6.60
Cognitive enhancers as adjuncts to psychotherapy: use of D-cycloserine in phobic individuals to facilitate extinction of fear. Arch Gen Psychiatry (2004) 5.26
Allele-specific FKBP5 DNA demethylation mediates gene-childhood trauma interactions. Nat Neurosci (2012) 4.71
Influence of child abuse on adult depression: moderation by the corticotropin-releasing hormone receptor gene. Arch Gen Psychiatry (2008) 4.65
Short term outcomes of prostate biopsy in men tested for cancer by prostate specific antigen: prospective evaluation within ProtecT study. BMJ (2012) 4.64
Behavioral and neural analysis of extinction. Neuron (2002) 4.53
Facilitation of conditioned fear extinction by systemic administration or intra-amygdala infusions of D-cycloserine as assessed with fear-potentiated startle in rats. J Neurosci (2002) 4.52
A randomized, double-blind evaluation of D-cycloserine or alprazolam combined with virtual reality exposure therapy for posttraumatic stress disorder in Iraq and Afghanistan War veterans. Am J Psychiatry (2014) 4.25
Role of the bed nucleus of the stria terminalis versus the amygdala in fear, stress, and anxiety. Eur J Pharmacol (2003) 4.08
Trauma exposure and stress-related disorders in inner city primary care patients. Gen Hosp Psychiatry (2009) 3.88
Different mechanisms of fear extinction dependent on length of time since fear acquisition. Learn Mem (2006) 3.30
Applying learning principles to the treatment of post-trauma reactions. Ann N Y Acad Sci (2003) 3.05
Genetic correction of PSA values using sequence variants associated with PSA levels. Sci Transl Med (2010) 2.83
Brain-derived neurotrophic factor and tyrosine kinase receptor B involvement in amygdala-dependent fear conditioning. J Neurosci (2004) 2.73
Characterization of Bouveret's syndrome: a comprehensive review of 128 cases. Am J Gastroenterol (2006) 2.58
A significant decline in the American domination of research in gastroenterology with increasing globalization from 1980 to 2005: an analysis of American authorship among 8,251 articles. Am J Gastroenterol (2008) 2.53
Emotion, motivation, and the brain: reflex foundations in animal and human research. Prog Brain Res (2006) 2.52
Impaired fear inhibition is a biomarker of PTSD but not depression. Depress Anxiety (2010) 2.27
Effect of 7,8-dihydroxyflavone, a small-molecule TrkB agonist, on emotional learning. Am J Psychiatry (2010) 2.25
How the neurocircuitry and genetics of fear inhibition may inform our understanding of PTSD. Am J Psychiatry (2010) 2.24
Pain symptomatology and pain medication use in civilian PTSD. Pain (2011) 2.16
Posttraumatic stress disorder among African Americans in an inner city mental health clinic. Psychiatr Serv (2005) 2.13
Fear conditioning, synaptic plasticity and the amygdala: implications for posttraumatic stress disorder. Trends Neurosci (2011) 2.12
Regulation of synaptic plasticity genes during consolidation of fear conditioning. J Neurosci (2002) 2.10
Using polymorphisms in FKBP5 to define biologically distinct subtypes of posttraumatic stress disorder: evidence from endocrine and gene expression studies. Arch Gen Psychiatry (2011) 2.09
The neuronal transporter gene SLC6A15 confers risk to major depression. Neuron (2011) 2.02
Estrogen levels are associated with extinction deficits in women with posttraumatic stress disorder. Biol Psychiatry (2012) 2.02
Fear extinction in traumatized civilians with posttraumatic stress disorder: relation to symptom severity. Biol Psychiatry (2010) 2.02
Role of the extended amygdala in short-duration versus sustained fear: a tribute to Dr. Lennart Heimer. Brain Struct Funct (2008) 1.97
Enhancing cannabinoid neurotransmission augments the extinction of conditioned fear. Neuropsychopharmacology (2005) 1.89
The role of amygdala glutamate receptors in fear learning, fear-potentiated startle, and extinction. Pharmacol Biochem Behav (2002) 1.87
Childhood maltreatment is associated with distinct genomic and epigenetic profiles in posttraumatic stress disorder. Proc Natl Acad Sci U S A (2013) 1.86
Differential immune system DNA methylation and cytokine regulation in post-traumatic stress disorder. Am J Med Genet B Neuropsychiatr Genet (2011) 1.83
Risk and resilience: genetic and environmental influences on development of the stress response. Depress Anxiety (2009) 1.79
Conditioned fear extinction and reinstatement in a human fear-potentiated startle paradigm. Learn Mem (2006) 1.78
Posttraumatic stress disorder may be associated with impaired fear inhibition: relation to symptom severity. Psychiatry Res (2009) 1.76
Amygdala-dependent fear is regulated by Oprl1 in mice and humans with PTSD. Sci Transl Med (2013) 1.74
Prelimbic cortical BDNF is required for memory of learned fear but not extinction or innate fear. Proc Natl Acad Sci U S A (2010) 1.72
Implications of memory modulation for post-traumatic stress and fear disorders. Nat Neurosci (2013) 1.72
Regulation of gephyrin and GABAA receptor binding within the amygdala after fear acquisition and extinction. J Neurosci (2005) 1.72
Conditioned pharmacotherapeutic effects: a preliminary study. Psychosom Med (2009) 1.68
Alterations in diurnal cortisol rhythm and acoustic startle response in nonhuman primates with adverse rearing. Biol Psychiatry (2005) 1.65
Association of CRP genetic variation and CRP level with elevated PTSD symptoms and physiological responses in a civilian population with high levels of trauma. Am J Psychiatry (2014) 1.60
Long-term therapy with aerosolized ribavirin for parainfluenza 3 virus respiratory tract infection in an infant with severe combined immunodeficiency. Pediatr Transplant (2007) 1.54
The renin-angiotensin pathway in posttraumatic stress disorder: angiotensin-converting enzyme inhibitors and angiotensin receptor blockers are associated with fewer traumatic stress symptoms. J Clin Psychiatry (2012) 1.54
Differential regulation of brain-derived neurotrophic factor transcripts during the consolidation of fear learning. Learn Mem (2004) 1.53
Impaired safety signal learning may be a biomarker of PTSD. Neuropharmacology (2011) 1.52
Glutamate receptors in extinction and extinction-based therapies for psychiatric illness. Neuropsychopharmacology (2010) 1.51
Fear potentiation and fear inhibition in a human fear-potentiated startle paradigm. Biol Psychiatry (2005) 1.49
Development of a new method for monitoring prostate-specific antigen changes in men with localised prostate cancer: a comparison of observational cohorts. Eur Urol (2009) 1.49
Timing of extinction relative to acquisition: a parametric analysis of fear extinction in humans. Behav Neurosci (2008) 1.45
Height and prostate cancer risk: a large nested case-control study (ProtecT) and meta-analysis. Cancer Epidemiol Biomarkers Prev (2008) 1.44
Training-induced changes in the expression of GABAA-associated genes in the amygdala after the acquisition and extinction of Pavlovian fear. Eur J Neurosci (2007) 1.43
Epigenomic association analysis identifies smoking-related DNA methylation sites in African Americans. Hum Genet (2013) 1.43
Effect of Childhood Trauma on Adult Depression and Neuroendocrine Function: Sex-Specific Moderation by CRH Receptor 1 Gene. Front Behav Neurosci (2009) 1.41
"Hidden" social networks in behavior change interventions. Am J Public Health (2015) 1.41
Circulating folate, vitamin B12, homocysteine, vitamin B12 transport proteins, and risk of prostate cancer: a case-control study, systematic review, and meta-analysis. Cancer Epidemiol Biomarkers Prev (2010) 1.40
Beta-catenin is required for memory consolidation. Nat Neurosci (2008) 1.40
DSM-5 and RDoC: progress in psychiatry research? Nat Rev Neurosci (2013) 1.38
Early interventions for PTSD: a review. Depress Anxiety (2012) 1.37
Early intervention may prevent the development of posttraumatic stress disorder: a randomized pilot civilian study with modified prolonged exposure. Biol Psychiatry (2012) 1.37
PTSD and gene variants: new pathways and new thinking. Neuropharmacology (2011) 1.34
Methylation quantitative trait loci (meQTLs) are consistently detected across ancestry, developmental stage, and tissue type. BMC Genomics (2014) 1.34
Learning-dependent structural plasticity in the adult olfactory pathway. J Neurosci (2008) 1.34
Pain medication use among patients with posttraumatic stress disorder. Psychosomatics (2006) 1.32
Brain-derived neurotrophic factor in amygdala-dependent learning. Neuroscientist (2005) 1.31
RGS14 is a natural suppressor of both synaptic plasticity in CA2 neurons and hippocampal-based learning and memory. Proc Natl Acad Sci U S A (2010) 1.31
Contingency awareness and fear inhibition in a human fear-potentiated startle paradigm. Behav Neurosci (2006) 1.30
Treatment barriers for low-income, urban African Americans with undiagnosed posttraumatic stress disorder. J Trauma Stress (2008) 1.29
The effect of gonadal hormones and gender on anxiety and emotional learning. Horm Behav (2006) 1.29
The Australian Intervention Randomized Control of Rate in Atrial Fibrillation Trial (AIRCRAFT). J Am Coll Cardiol (2003) 1.29
Glutamate receptor antagonist infusions into the basolateral and medial amygdala reveal differential contributions to olfactory vs. context fear conditioning and expression. Learn Mem (2005) 1.28
Emotion dysregulation and negative affect: association with psychiatric symptoms. J Clin Psychiatry (2011) 1.27
Accounting for population stratification in DNA methylation studies. Genet Epidemiol (2014) 1.25
AX+, BX- discrimination learning in the fear-potentiated startle paradigm: possible relevance to inhibitory fear learning in extinction. Learn Mem (2004) 1.24
Emotional learning and glutamate: translational perspectives. CNS Spectr (2005) 1.23
Temporary disruption of fear-potentiated startle following PKMζ inhibition in the amygdala. Nat Neurosci (2011) 1.23
Light-enhanced startle: further pharmacological and behavioral characterization. Psychopharmacology (Berl) (2001) 1.21
Involvement of central amygdalar and bed nucleus of the stria terminalis corticotropin-releasing factor in behavioral responses to social defeat. Behav Neurosci (2004) 1.20
Moderating effects of resilience on depression in individuals with a history of childhood abuse or trauma exposure. J Affect Disord (2010) 1.20
Dark-enhanced startle responses and heart rate variability in a traumatized civilian sample: putative sex-specific correlates of posttraumatic stress disorder. Psychosom Med (2012) 1.20
Pharmacological treatments that facilitate extinction of fear: relevance to psychotherapy. NeuroRx (2006) 1.20
Relationship of enhanced norepinephrine activity during memory consolidation to enhanced long-term memory in humans. Am J Psychiatry (2002) 1.18
Association of folate-pathway gene polymorphisms with the risk of prostate cancer: a population-based nested case-control study, systematic review, and meta-analysis. Cancer Epidemiol Biomarkers Prev (2009) 1.18
Olfactory-mediated fear-potentiated startle. Behav Neurosci (2002) 1.18
Neural correlates of attention bias to threat in post-traumatic stress disorder. Biol Psychol (2012) 1.17
Daily living with distress and enrichment: the moral experience of families with ventilator-assisted children at home. Pediatrics (2006) 1.17
Quantifying fear potentiated startle using absolute versus proportional increase scoring methods: implications for the neurocircuitry of fear and anxiety. Psychopharmacology (Berl) (2002) 1.16
Effects of the beta-blocker propranolol on cued and contextual fear conditioning in humans. Psychopharmacology (Berl) (2004) 1.16